ストックスクリーナーアプリを入手
0.7025
0.36%
0.0025
プレマーケット:
.70
-0.0025
-0.36%
前日終値:
$0.70
開ける：
$0.6914
24時間の取引高:
3.13M
Relative Volume:
0.85
時価総額：
$208.85M
収益：
-
当期純損益:
$-63.08M
株価収益率:
-2.6019
EPS:
-0.27
ネットキャッシュフロー:
$-72.53M
1週間 パフォーマンス:
-1.78%
1か月 パフォーマンス:
+1.75%
6か月 パフォーマンス:
-26.68%
1年 パフォーマンス:
-61.19%
1日の値動き範囲:
$0.671
$0.7175
1週間の範囲:
$0.65
$0.735
52週間の値動き範囲:
$0.515
$2.06
Ocugen Inc Stock (OCGN) Company Profile
OCGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
0.7025 | 208.85M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.00 | 115.57B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
574.16 | 60.30B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
542.47 | 37.56B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.86 | 35.18B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
224.73 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-15 | 開始されました | Maxim Group | Buy |
| 2023-03-01 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | 開始されました | Mizuho | Buy |
| 2022-06-15 | 再開されました | ROTH Capital | Buy |
| 2022-06-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-07-26 | 開始されました | Noble Capital Markets | Outperform |
| 2021-06-11 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2021-05-07 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | アップグレード | H.C. Wainwright | Neutral → Buy |
すべてを表示
Ocugen Inc (OCGN) 最新ニュース
Ocugen to Host Q1 2025 Earnings Call and Business Update on May 9 - MSN
Ocugen stock price target cut to $7 by H.C. Wainwright - Investing.com Nigeria
Ocugen (OCGN) Price Target Reduced by H.C. Wainwright | OCGN Sto - GuruFocus
Ocugen (OCGN) Maintains 'Buy' Rating Despite Price Target Adjust - GuruFocus
Ocugen (OCGN) Receives Ongoing "Buy" Rating from Chardan Capital - GuruFocus
The Analyst Verdict: Ocugen In The Eyes Of 5 Experts - Benzinga
Ocugen outlines 2025 milestones for gene therapy programs with BLA filings on track - MSN
Ocugen, Inc. (NASDAQ:OCGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Ocugen: Q1 Earnings Snapshot - San Francisco Chronicle
Ocugen Inc (OCGN) Q1 2025 Earnings Call Highlights: Strategic Advances in Gene Therapy Amid ... - Yahoo
Earnings call transcript: Ocugen’s Q1 2025 loss narrows, stock rises By Investing.com - Investing.com India
Ocugen Inc (OCGN) Q1 2025 Earnings Call Highlights: Strategic Advances in Gene Therapy Amid ... By GuruFocus - Investing.com Canada
Earnings call transcript: Ocugen’s Q1 2025 loss narrows, stock rises - Investing.com
Ocugen’s Q1 2025: Progress in Gene Therapy Trials - TipRanks
Ocugen Inc’s Earnings Call: Optimism Amid Financial Challenges - TipRanks
Ocugen Provides Business Update with First Quarter 2025 Financia - GuruFocus
Ocugen Q1 2025 Earnings Call Transcript - MarketBeat
Ocugen (OCGN) Reveals Strong Q1 Revenue Growth and Strategic Cli - GuruFocus
Ocugen Provides Business Update with First Quarter 2025 Financial Results - Ocugen
Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish By Stocktwits - Investing.com India
Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish - MSN
Ocugen (OCGN) Set to Release Q1 Earnings with Minimal Revenue Ex - GuruFocus
A Look at Ocugen's Upcoming Earnings Report - Nasdaq
Ocugen (OCGN) Set to Release Q1 Earnings with Minimal Revenue Expectations - GuruFocus
Ocugen to Showcase Gene Therapy Advances at Upcoming Ophthalmology Conferences - MSN
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET - GuruFocus
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results | OCGN Stock News - GuruFocus
Ocugen, Inc. to Host Conference Call for Q1 2025 Financial Results and Business Update - Nasdaq
Ocugen to Host Conference Call on Friday, May 9 at 8:30 - GlobeNewswire
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results - TradingView
Gene Therapy Pioneer Ocugen Sets Q1 2025 Earnings Call to Reveal Blindness Treatment Progress - Stock Titan
Ocugen to Present at Eyecelerator Conference May 2025 - TipRanks
Ocugen to Present on Modifier Gene Therapy Platform at Associati - GuruFocus
OCUGEN Earnings Preview: Recent $OCGN Insider Trading, Hedge Fund Activity, and More - Nasdaq
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress - Ocugen
Stock Quote & Chart - Ocugen
Ocugen, Inc. to Showcase Innovative Modifier Gene Therapy Platform at Upcoming ARVO and Retina World Congress Meetings - Nasdaq
Ocugen to Present on Modifier Gene Therapy Platform at - GlobeNewswire
Revolutionary Gene Therapy Platform: Ocugen Presents Phase 3 Trial Results for Multiple Eye Diseases - Stock Titan
O’Reilly Automotive: An Anytime Buy for Buy-and-Hold Investors - The Globe and Mail
Press Release Distribution & PR Platform - ACCESS Newswire
Form DEF 14A Ocugen, Inc. For: Jun 05 - StreetInsider
Ocugen, Inc. Announces Directorate Resignations - marketscreener.com
Ocugen Inc (OCGN) 財務データ
収益
当期純利益
現金流量
EPS
Ocugen Inc (OCGN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Castillo Kirsten | Director |
Nov 22 '24 |
Buy |
0.91 |
25,000 |
22,848 |
75,000 |
3.01%
大文字化:
|
ボリューム (24 時間):